Leptin in bipolar disorder: A systematic review and meta-analysis

European Psychiatry

Volumn 35, Issue , 2016, Pages 1-7

  Fernandes, B S ^a,b   Dash, S ^a   Jacka, F ^a   Dodd, S ^a,e   Carvalho, A F ^c   Kohler C A ^c   Steiner, J ^d   da Graca Cantarelli M ^b   Nardin, P ^b   Goncalves C A ^b   Berk, M ^a,e  

^a DEAKIN UNIVERSITY   (Australia)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Biomarker; Bipolar disorder; Depression; Leptin; Mania; Meta analysis

Indexed keywords

BIOLOGICAL MARKER; LEPTIN;

BIPOLAR DISORDER; DEPRESSION; EFFECT SIZE; HUMAN; MANIA; MOOD; PRIORITY JOURNAL; PUBLISHING; SENSITIVITY ANALYSIS; SHORT SURVEY; SYSTEMATIC REVIEW; ADULT; BLOOD; CYCLOTHYMIA; FEMALE; MALE; META ANALYSIS;

ADULT; BIPOLAR DISORDER; CYCLOTHYMIC DISORDER; DEPRESSION; FEMALE; HUMANS; LEPTIN; MALE;

EID: 84962765092     PISSN: 09249338     EISSN: 17783585     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2016.02.003     Document Type: Short Survey

References (44)

1. Grande I., Berk M., Birmaher B., Vieta E. Bipolar disorder. Lancet 2015.
2. McElroy S.L., Keck P.E. Metabolic syndrome in bipolar disorder: a review with a focus on bipolar depression. J Clin Psychiatry 2014, 75:46-61.
3. Vancampfort D., Vansteelandt K., Correll C.U., Mitchell A.J., De Herdt A., Sienaert P., et al. Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators. Am J Psychiatry 2013, 170:265-274.
4. Debnath M., Agrawal S., Agrawal A., Dubey G.P. Metaflammatory responses during obesity: pathomechanism and treatment. Obes Res Clin Pract 2015.
5. Brietzke E., Stertz L., Fernandes B., Kauer-Sant'anna M., Mascarenhas M., Vargas A. Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord 2009, 116:214-217.
6. da Graca Cantarelli M., Nardin P., Buffon A., Eidt M.C., Antonio Godoy L., Fernandes B.S., et al. Serum triglycerides, but not cholesterol or leptin, are decreased in suicide attempters with mood disorders. J Affect Disord 2014, 172C:403-409.
7. Fernandes B.S., Steiner J., Bernstein H.G., Dodd S., Pasco J.A., Dean O.M., et al. C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications. Mol Psychiatry 2015.
8. Kunz M., Cereser K.M., Goi P.D., Fries G.R., Teixeira A.L., Fernandes B.S., et al. Serum levels of IL-6, IL-10 and TNF-alpha in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance. Rev Bras Psiquiatr 2011, 33:268-274.
9. Santoro A., Mattace Raso G., Meli R. Drug targeting of leptin resistance. Life Sci 2015, 140:64-74.
10. Steiner J., Bernstein H.G., Schiltz K., Muller U.J., Westphal S., Drexhage H.A., et al. Immune system and glucose metabolism interaction in schizophrenia: a chicken-egg dilemma. Prog Neuropsychopharmacol Biol Psychiatry 2014, 48:287-294.
11. Atmaca M., Kuloglu M., Tezcan E., Ustundag B., Bayik Y. Serum leptin and cholesterol levels in patients with bipolar disorder. Neuropsychobiology 2002, 46:176-179.
12. Barbosa I.G., Rocha N.P., de Miranda A.S., Magalhaes P.V., Huguet R.B., de Souza L.P., et al. Increased levels of adipokines in bipolar disorder. J Psychiatr Res 2012, 46:389-393.
13. Chang H.H., Gean P.W., Chou C.H., Yang Y.K., Tsai H.C., Lu R.B., et al. C825T polymorphism of the GNB3 gene on valproate-related metabolic abnormalities in bipolar disorder patients. J Clin Psychopharmacol 2010, 30:512-517.
14. Cordas G., Gazal M., Schuch E.M., Spessato B.C., Branco J., Jansen K., et al. Leptin in depressive episodes: is there a difference between unipolar and bipolar depression?. Neuroendocrinology 2015, 101:82-86.
15. Gergerlioglu H.S., Savas H.A., Celik A., Savas E., Yumru M., Tarakcioglu M., et al. Atypical antipsychotic usage-related higher serum leptin levels and disabled lipid profiles in euthymic bipolar patients. Neuropsychobiology 2006, 53:108-112.
16. Guler O. Ghrelin and leptin levels in patients with euthymic bipolar disorder and bipolar depression. Neurol Psychiatry Brain Res 2007, 14:4.
17. Kurt E., Guler O., Serteser M., Cansel N., Ozbulut O., Altinbas K., et al. The effects of electroconvulsive therapy on ghrelin, leptin and cholesterol levels in patients with mood disorders. Neurosci Lett 2007, 426:49-53.
18. Rosso G., Cattaneo A., Zanardini R., Gennarelli M., Maina G., Bocchio-Chiavetto L. Glucose metabolism alterations in patients with bipolar disorder. J Affect Disord 2015, 184:293-298.
19. Soeiro-de-Souza M.G., Gold P.W., Brunoni A.R., de Sousa R.T., Zanetti M.V., Carvalho A.F., et al. Lithium decreases plasma adiponectin levels in bipolar depression. Neurosci Lett 2014, 564:111-114.
20. Tsai S.Y., Chung K.H., Huang S.H., Chen P.H., Lee H.C., Kuo C.J. Persistent inflammation and its relationship to leptin and insulin in phases of bipolar disorder from acute depression to full remission. Bipolar Disord 2014, 16:800-808.
21. Tsai S.Y., Chung K.H., Wu J.Y., Kuo C.J., Lee H.C., Huang S.H. Inflammatory markers and their relationships with leptin and insulin from acute mania to full remission in bipolar disorder. J Affect Disord 2012, 136:110-116.
22. Lau J., Ioannidis J.P., Schmid C.H. Quantitative synthesis in systematic reviews. Ann Intern Med 1997, 127:820-826.
23. Higgins J.P. Handbook for Systematic reviews of Interventions Version 5.1.0 2011, The Cochrane Collaboration.
24. Egger M., Zellweger-Zahner T., Schneider M., Junker C., Lengeler C., Antes G. Language bias in randomised controlled trials published in English and German. Lancet 1997, 350:326-329.
25. Soeken K.L., Sripusanapan A. Assessing publication bias in meta-analysis. Nurs Res 2003, 52:57-60.
26. Sistrom C.L., Mergo P.J. A simple method for obtaining original data from published graphs and plots. Am J Roentgenol 2000, 174:1241-1244.
27. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997, 315:629-634.
28. Duval S., Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000, 56:455-463.
29. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. Br Med J 2003, 327:557-560.
30. Bowden J., Tierney J.F., Copas A.J., Burdett S. Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics. BMC Med Res Methodol 2011, 11:41.
31. Williams L.J., Pasco J.A., Henry M.J., Jacka F.N., Dodd S., Nicholson G.C., et al. Lifetime psychiatric disorders and body composition: a population-based study. J Affect Disord 2009, 118:173-179.
32. Girshkin L., Matheson S.L., Shepherd A.M., Green M.J. Morning cortisol levels in schizophrenia and bipolar disorder: a meta-analysis. Psychoneuroendocrinology 2014, 49:187-206.
33. Pasco J.A., Gould H., Brennan S.L., Nicholson G.C., Kotowicz M.A. Musculoskeletal deterioration in men accompanies increases in body fat. Obesity (Silver Spring) 2014, 22:863-867.
34. Kapczinski F., Fernandes B., Kauer-Sant'anna M., Gama C., Yatham L. The concept of staging in bipolar disorder: the role of BDNF and TNF-alpha as biomarkers. Acta Neuropsychiatr 2009, 21:272-274.
35. Lee H.J., Kim S.H., Kim E.Y., Lee N.Y., Yu H.Y., Kim Y.S., et al. Leptin is associated with mood status and metabolic homeostasis in patients with bipolar disorder. Neuropsychobiology 2014, 70:203-209.
36. Stubbs B., Wang A.K., Vancampfort D., Miller B.J. Are leptin levels increased among people with schizophrenia versus controls? A systematic review and comparative meta-analysis. Psychoneuroendocrinology 2016, 63:144-154.
37. Fernandes B.S., Gama C.S., Cereser K.M., Yatham L.N., Fries G.R., Colpo G., et al. Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis. J Psychiatr Res 2011, 45:995-1004.
38. Fernandes B.S., Molendijk M.L., Kohler C.A., Soares J.C., Leite C.M., Machado-Vieira R., et al. Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies. BMC Med 2015, 13:289.
39. Berk M., Kapczinski F., Andreazza A.C., Dean O.M., Giorlando F., Maes M., et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 2011, 35:804-817.
40. Fernandes B.S., Steiner J., Berk M., Molendijk M.L., Gonzalez-Pinto A., Turck C.W., et al. Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications. Mol Psychiatry 2015, 20:1108-1119.
41. Fernandes B.S., Berk M., Turck C.W., Steiner J., Goncalves C.A. Decreased peripheral brain-derived neurotrophic factor levels are a biomarker of disease activity in major psychiatric disorders: a comparative meta-analysis. Mol Psychiatry 2014, 19:749-751.
42. Kolaczynski J.W., Considine R.V., Ohannesian J., Marco C., Opentanova I., Nyce M.R., et al. Responses of leptin to short-term fasting and refeeding in humans: a link with ketogenesis but not ketones themselves. Diabetes 1996, 45:1511-1515.
43. Knutson K.L., Spiegel K., Penev P., Van Cauter E. The metabolic consequences of sleep deprivation. Sleep Med Rev 2007, 11:163-178.
44. Minocci A., Savia G., Lucantoni R., Berselli M.E., Tagliaferri M., Calo G., et al. Leptin plasma concentrations are dependent on body fat distribution in obese patients. Int J Obes Relat Metab Disord 2000, 24:1139-1144.